Largest study of 'post-treatment controllers' reveals clues about HIV remission

September 13, 2018, Brigham and Women's Hospital
Credit: CC0 Public Domain

Most HIV patients need to take daily anti-retroviral therapy—if they suspend treatment, HIV will rebound within 3-4 weeks. But clinical trials have revealed that a small fraction of patients can stop taking medications yet keep the virus suppressed for 24 weeks or longer, maintaining viral control without the assistance of medication.

Much remains unknown about this unique group of individuals, known as HIV post-treatment controllers, including how rare this ability is. Two new studies—including the largest study of post-treatment controllers to date—explore the characteristics of this group as well as the that may help explain this unique ability.

"Post-treatment controllers represent a natural model of sustained remission," said Jonathan Li, MD, of Brigham and Women's Hospital's Infectious Disease Clinic and lead author on both studies. "Understanding these individuals can lead to new insights for HIV therapies."

The researchers defined post-treatment controllers as having viral loads of 400 or fewer copies per milliliter of blood plasma for at least 24 weeks' post-treatment interruption. The study characterized 67 post-treatment controllers, the largest cohort to date. They found these post-treatment controllers by sifting through data collected from over 700 participants in 14 clinical studies involving treatment interruption.

The CHAMP (Control of HIV after Antiretroviral Medication Pause) study, published in The Journal of Infectious Disease, examined what post-treatment control can tell us about HIV's progression. The researchers observed that individuals treated early were significantly more likely to become post-treatment controllers. Previously published studies have found other benefits for early treatment, notably decreased risk of transmission to partners compared to treatment starting during chronic infection.

A second study published in The Journal of Clinical Investigation illuminated the biological mechanisms underlying post-treatment control. Li's team sequenced viral DNA, which the HIV virus had woven into the patient's DNA.

The team observed that post-treatment controllers had lower levels of intact viral DNA prior to . In other words, post-treatment controllers carried smaller viral reservoirs. Li believes that reservoir size could represent a useful biomarker to help predict which patients will become post-treatment controllers.

In addition to intact viral DNA, Li and his team found that reservoirs of defective viral DNA may offer novel insights for treating HIV. They observed that defective HIV DNA seemed to give rise to proteins that could interact with the immune system. They plan to study this further.

"Each year, there are millions of new HIV infections," said Li. "The results of these studies may help inform the design of strategies and trials aimed at achieving HIV remission, which we hope will bend the curve of this epidemic."

Explore further: Study supports use of short-term HIV treatment interruption in clinical trials

More information: Radwa Sharaf et al, HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers, Journal of Clinical Investigation (2018). DOI: 10.1172/JCI120549

Related Stories

Study supports use of short-term HIV treatment interruption in clinical trials

January 11, 2018
A short-term pause in HIV treatment during a carefully monitored clinical trial does not lead to lasting expansion of the HIV reservoir nor cause irreversible damage to the immune system, new findings suggest.

Mathematical model seeks functional cure for HIV

April 27, 2015
(Medical Xpress)—Individuals with the natural ability to control HIV infection in the absence of treatment are referred to as elite controllers (ECs). Such individuals maintain undetectable viral loads less than 50 copies ...

Benefits of early antiretroviral therapy in HIV-infected children

July 26, 2018
Without treatment, an HIV-infected child is at greater risk of disease progression to AIDS than an adult. Initiation of early treatment in infants shows an undeniable clinical benefit by reducing the risk of death in early ...

French patients keep HIV at bay despite stopping drugs (Update)

March 14, 2013
A small French study of 14 HIV patients who have remained healthy for years after stopping drug treatment offers fresh evidence that early medical intervention may lead to a "functional cure" for AIDS, researchers said Thursday.

VRC01 antibody prolonged time to HIV viral rebound after treatment interruption

July 25, 2017
A new study has shown that infusion of a broadly neutralizing antibody (bNAb) in virally suppressed, early treated volunteers was associated with a modestly delayed rebound of HIV after interruption of antiretroviral therapy ...

Recommended for you

Research reveals details of how HIV becomes infectious

November 13, 2018
HIV, the virus that causes AIDS, has been studied extensively ever since the AIDS epidemic was officially recognized by health professionals in the early 1980s.

Cellphone technology developed to detect HIV

November 9, 2018
The management of human immunodeficiency virus 1 (HIV), an autoimmune disorder that cripples the immune system by attacking healthy cells, remains a major global health challenge in developing countries that lack infrastructure ...

Long-term study shows that HIV-2 is deadlier than previously thought

November 8, 2018
A study published in The Lancet HIV shows that HIV-2 is more pathogenic than previously demonstrated. The new findings indicate that early treatment should be applied to all patients with HIV, not only to those with HIV-1.

Incarceration is likely to increase HIV and HCV transmission among people who inject drugs, new study finds

October 30, 2018
Injecting drug use, through the sharing of needles, syringes and other injecting equipment, is a primary route of transmission for both HIV and hepatitis C virus (HCV), blood-borne infections that cause considerable morbidity ...

Long-acting injectable implant shows promise for HIV treatment and prevention

October 9, 2018
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results.

Scientists develop rapid test for diagnosing tuberculosis in people with HIV

October 8, 2018
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Anonym708893
not rated yet Oct 18, 2018
Hello everyone i am happy to say that i was cure from HIV/AIDS by Dr OMOLOWA with his herbal medications after i tested positive july 2016 and ever since then i have been on medications to extend my living on earth. One faithful day i was searching on line if i could get some tips on how to cure my illness and i saw a comment on how Dr OMOLOWA cure HIV with herbs,i was surprise and i contact him on the email they provided on the comment and i explain my problem to him and he also prepare the herbs and send to me which i use for one week as i was instructed by him and after 2weeks i went to hospital for checkup and i tested Negative and i am fully cured from the disease and i am so greatful to Dr OMOLOWA.You can also reach Dr OMOLOWA on his email: dr.omolowa@gmail.com or you can call and whatsapp him +2349039377739
Anonym565542
not rated yet Oct 25, 2018

i want to thank Dr Eboh for the herbal HIV medicine he gave to me and my daughter, i was suffering from HIV when i gave birth to my daughter and that was how my daughter got the sickness indirect from me, but to God be the glory that i am heal with the herbal medicine that Dr Eboh gave to me when i contacted him. i want to use this medium to tell everyone that the solution to our sickness has come, so i will like you to contact this great healer on his email address: holycurecenter@gmail.com with him all your pains will be gone, i am really happy today that i and my daughter are cured of HIV, we are now negative after the use of his medicine,my doctor confirm it. once more i say a big thank to you Dr Eboh for healing hands upon my life and my daughter, i say may God continue to bless you abundantly and give you more power to keep helping those that want your help in their lives. email him now he is waiting to receive you. holycurecenter@gmail.com or add him on whatsapp +234805382381
standard626
not rated yet Oct 26, 2018
Hello viewers please help me thank Dr Agbada Oduntun who saved my life from hepatitis B virus with his Herb cure, I will forever remain Grateful for what God use him to do in my family. You can reach out to him through his email. droduntunherbalhomecure@gmail,com or whatsapp him for similar diseases like HIV, STD,TB,Cancer, and many other on +2349039463501,for similar diseases. Please share this information to your friends and loved ones and save people from death

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.